Management of cholestatic pruritus in paediatric patients with alagille syndrome: The king's college hospital experience

Journal of Pediatric Gastroenterology and Nutrition

Volumn 57, Issue 2, 2013, Pages 149-154

  Kronsten, Victoria ^a   Fitzpatrick, Emer ^a   Baker, Alastair ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Alagille syndrome; antipruritic medications; cholestatic pruritus

Indexed keywords

ALIMEMAZINE; ANTIHISTAMINIC AGENT; COLESTYRAMINE; NALTREXONE; ONDANSETRON; PHENOBARBITAL; RIFAMPICIN; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ALAGILLE SYNDROME; ALBUMIN DIALYSIS; ARTICLE; CHILD; CHILDHOOD DISEASE; CHOLESTASIS; CHOLESTATIC PRURITUS; DIARRHEA; DISEASE SEVERITY; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; END STAGE LIVER DISEASE; EVENING DOSAGE; FAILURE TO THRIVE; FEMALE; HUMAN; INFANT; INTRACTABLE PRURITUS; IRRITABILITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; METABOLIC BONE DISEASE; NAUSEA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PORTAL HYPERTENSION; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RASH; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SURVIVAL RATE; VOMITING;

ADOLESCENT; ALAGILLE SYNDROME; ANTIPRURITICS; CHILD; CHILD, PRESCHOOL; CHOLESTASIS; DIALYSIS; FEMALE; HUMANS; INFANT; LIVER TRANSPLANTATION; MALE; PRURITUS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84881024600     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318297e384     Document Type: Article

References (26)

1. Lykavieris P, Hadchouel M, Chardot C, et al. Outcome of liver disease in children with Alagille syndrome, a study of 163 patients. Gut 2001;49:431-5.
2. Narkewicz MR, Smith D, Gregory C, et al. Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease. J Pediatr Gastroenterol Nutr 1998;26:49-55.
3. Kamath BM, Loomes KM, Piccoli DA. Medical management of Alagille syndrome. J Pediatr Gastroenterol Nutr 2010;50:580-6.
4. Kuiper EM, Van Erpecum KJ, Beuers U, et al. The potent bile acid sequestrant colesevalam is not effective in cholestatic pruritus: results of a double-blind, randomised, placebo-controlled trial. Hepatology 2010;52:1334-40.
5. Hoffenberg EJ, Narkewicz MR, Sondheimer JM, et al. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr 1995;27:220-4.
6. Chang Y, Golkar L. The use of naltrexone in the management of severe generalised pruritus in biliary atresia: report of a case. Pediatr Dermatol 2008;25:403-4.
7. Ghent CN, Bloomer JR, Klatskin G. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus. Gastroenterology 1977;73:1125-30.
8. Emerick KM, Whitington PF. Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome. Hepatology 2002;35:1501-6.
9. Jones EA, Bergasa NV. The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology 1990;11:884-7.
10. Stander S, Steinhoff M, Schmelz M, et al. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 2003;139: 1463-70.
11. Mela M, Mancuso A, Burroughs AK. Pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther 2003;17:857-70.
12. O'Donohue JW, Pereira SP, Ashdown AC. A controlled trial of ondan-setron in the pruritus of cholestasis. Aliment Pharmacol Ther 2005; 21:1041-5.
13. Cies JJ, Giamalis JN. Treatment of cholestatic pruritus in children. Am J Health Syst Pharm 2007;64:1157-62.
14. Balistreri WF. Bile acid therapy in paediatric hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr 1997; 24:573-89.
15. Yerushalmi B, Sokol RJ, Narkewicz MR, et al. Use of rifampin for severe pruritus in children with chronic cholestasis. J Pediatr Gastro-enterol Nutr 1999;29:442-7.
16. Wietholtz H, Marschall HU, Sjovall J, et al. Stimulation of bile acid 6[alpha]-hydroxylation by rifampin. J Hepatol 1996;24:713-8.
17. Grosset J, Leventis S. Adverse effects of rifampin. Rev Infect Dis 1983;3:S440-50.
18. Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children. J Pediatr Gastroenterol Nutr 2010;51:787-9.
19. Muller C, Pongratz S, Pidlich J, et al. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomised, placebo-controlled, double blind cross-over trial. Eur J Gastroenterol Hepatol 1998;10:865-70.
20. Neimark E, Schneider B. Novel surgical and pharmacological approaches to chronic cholestasis in children: partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome. J Pediatr Gastroenterol Nutr 2003;36:296-7.
21. Yang H. Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease. J Pediatr Gastro-enterol Nutr 2009;49:216-21.
22. Modi BP, Suh MY, Jonas MM, et al. Ileal exclusion for refractory symptomatic cholestasis in Alagille syndrome. J Pediatr Surg 2007; 42:800-5.
23. Kamath BM, Schwarz KB, Hadzic N. Alagille syndrome and liver transplantation. J Pediatr Gastroenterol Nutr 2010;50:11-5.
24. Emerick KM, Rand EB, Goldmuntz E, et al. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatol-ogy 1999;29:822-9.
25. Pares A, Herrera M, Aviles J, et al. Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. J Hepatol 2010;53:307-12.
26. Kamath BM, Yin W, Miller H. Outcomes of liver transplantation for patients with Alagille syndrome: the studies of paediatric liver transplantation experience. Liver Transpl 2012;18:940-8.